Wide Ranks

KTTA

Pasithea Therapeutics Corp.

2.90

Top Statistics
Market Cap 3 M Forward PE -4.08 Revenue Growth 0.00 %
Current Ratio 6.20 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.2780 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 7 M Total Cash Per Share 7.63 Total Debt
Total Debt To Equity Current Ratio 6.20 Book Value Per Share 22.46
All Measures
Short Ratio 32.00 % Message Board Id finmb_702706441 Shares Short Prior Month 171290
Return On Equity -0.6325 City Miami Beach Uuid f19ed9f9-de4f-3b85-b823-68e1246ae624
Previous Close 3.08 First Trade Date Epoch Utc 1 B Book Value 22.46
Beta 0.8210 Volume 23300 Price To Book 0.1291
Last Split Date 1 B Fifty Two Week Low 2.87 Total Cash Per Share 7.63
Shares Short Previous Month Date 1 B Max Age 86400 Sand P52 Week Change 0.3133
Net Income To Common -16370943 Short Percent Of Float 0.0140 Implied Shares Outstanding 1 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 94950
Average Volume10days 94950 Total Cash 7 M Next Fiscal Year End 1 B
Held Percent Insiders 0.2312 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 3.08 Target Low Price 0.0000
Gmt Off Set Milliseconds -18000000 Fifty Day Average 4.07 Open 3.09
Free Cashflow -9018887 State FL Dividend Yield 0.00 %
Return On Assets -0.3790 Time Zone Short Name EST Trailing Eps -14.79
Day Low 2.87 Address1 1111 Lincoln Road Shares Outstanding 1 M
Price Hint 4 Target High Price 0.0000 Website https://www.pasithea.com
52 Week Change -0.5552 Average Volume 948053 Forward Eps -0.7100
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 571.20 %
Last Split Factor 1:20 Regular Market Day High 3.09 Is_sp_500 False
Profit Margins 0.00 % Fifty Two Week High 17.40 Day High 3.09
Shares Short 11581 Regular Market Open 3.09 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0111
Operating Cashflow -14920285 Currency USD Time Zone Full Name America/New_York
Market Cap 3 M Is_nasdaq_100 False Zip 33139
Quote Type EQUITY Industry Biotechnology Long Name Pasithea Therapeutics Corp.
Regular Market Day Low 2.87 Held Percent Institutions 0.0287 Current Price 2.90
Address2 Suite 500 Enterprise To Ebitda 0.2780 Financial Currency USD
Current Ratio 6.20 Industry Disp Biotechnology Country United States
Float Shares 802648 Two Hundred Day Average 5.60 Enterprise Value -4522101
Forward PE -4.08 Regular Market Volume 23300 Ebitda -16274925
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Pasithea Therapeutics Corp.

, a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases.

Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications.

The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia.

Pasithea Therapeutics Corp.

was incorporated in 2020 and is headquartered in Miami Beach, Florida.